Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 4:24 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2953–2976 of 3,983 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Breast Cancer, Cognitive Impairments
Interventions: Arm 1: Computerized Cognitive Training-Global Stimulation Games, Arm 2: Computerized Cognitive Training-Neuroplasticity Games; Behavioral
Lead sponsor: NRG Oncology; Other
Eligibility: 18 Years to 100 Years
Enrollment: 386 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 673
States / cities: Anchorage, Alaska • Fairbanks, Alaska • Gilbert, Arizona + 483 more

Conditions: Erectile Dysfunction
Interventions: Levitra (Vardenafil, BAY38-9456), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 229 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 18
States / cities: Phoenix, Arizona • Beverly Hills, California • Irvine, California + 14 more

Conditions: Cognitive Impairment, Cognitive Decline, Cognition Disorders in Old Age, Well-Being, Psychological, Inflammation, Cognitive Fun
Interventions: LasoperinTM, Placeo; Dietary Supplement
Lead sponsor: Lindenwood University; Other
Eligibility: 30 Years to 60 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Saint Charles, Missouri

Conditions: Low-grade Glioma
Interventions: ReMind iPad app, Healthy SMS texting, In-person cognitive rehabilitation, Telehealth cognitive rehabilitation; Device · Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Tachycardia, Ventricular, Heart Failure, Congestive, Ventricular Fibrillation, Ventricular Dysfunction, Bradycardia
Interventions: Not listed
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 3,032 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 113
States / cities: Tucson, Arizona • Little Rock, Arkansas • Fresno, California + 107 more

Conditions: Cognitive Dysfunction, Alzheimer Disease, Blood-Brain Barrier, Apolipoprotein E, Deficiency or Defect of, Brain Aging, Fatty Acids, Omega-3
Interventions: Alpha-Linolenic Acid (2.6 g/day), Placebo Control Group; Drug · Dietary Supplement
Lead sponsor: Michal Schnaider Beeri, Ph.D.; Other
Eligibility: 60 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Spinal Cord Injury, Neurogenic Bladder (NB), Neurogenic Lower Urinary Tract Dysfunction, Multiple Sclerosis, Spina Bifida, Urinary Tract Infection(UTI)
Interventions: Gentamicin, Lactobacillus Rhamnosus GG; Drug
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Pittsburgh, Pennsylvania

Conditions: Myocardial Dysfunction, Heart Failure, Inflammation
Interventions: Dapagliflozin, MRI scan, CMR imaging; Drug · Device
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 90 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Alzheimer Disease
Interventions: Routine Care Documentation; Other
Lead sponsor: Alzheimer's Disease and Related Disorders Association, Inc; Other
Eligibility: 18 Years and older
Enrollment: 20,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2032
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Prostate Cancer, Erectile Dysfunction Following Radical Prostatectomy, Urinary Incontinence
Interventions: Intensive Fitness Intervention, TRIMM; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 40 Years to 65 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Mild Cognitive Impairment, Alzheimer Disease
Interventions: Not listed
Lead sponsor: Baylor Research Institute; Other
Eligibility: 40 Years and older
Enrollment: 95 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2021
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Kidney Disease
Interventions: Allopurinol, Placebo; Drug · Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Hypertension, Atherosclerosis
Interventions: Not listed
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 50 Years to 90 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Evaporative Dry Eye Disease, Meibomian Gland Dysfunction
Interventions: ELM; Device
Lead sponsor: Eyedetec Medical, Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Citrus Heights, California

Conditions: Female Sexual Dysfunction, Overactive Bladder
Interventions: Anticholinergic, PTNS; Drug · Procedure
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 5
States / cities: Washington D.C., District of Columbia • Indianapolis, Indiana • Louisville, Kentucky + 2 more

Conditions: Alzheimer Disease, Cognitive Decline, Aging
Interventions: California Cognitive Assessment Battery; Diagnostic Test
Lead sponsor: Neurobehavioral Systems, Inc.; Industry
Eligibility: 18 Years to 89 Years
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Sleep, Mild Cognitive Impairment, Mood Disorders
Interventions: Light therapy; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 65 Years to 99 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Redwood City, California

Conditions: Lower Extremity Dysfunction, Stroke
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 99 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Alzheimer Disease
Interventions: [11C]-Pittsburgh Compound B ([11C]PiB), F 18 AV-1451 (Flortaucipir); Drug
Lead sponsor: Tammie L. S. Benzinger, MD, PhD; Other
Eligibility: 18 Years and older
Enrollment: 650 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Meibomian Gland Dysfunction, Dry Eye, Posterior Blepharitis
Interventions: Blephex, MiboFlo; Device
Lead sponsor: University of the Incarnate Word; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Major Depressive Disorder (MDD)
Interventions: Extended-Release Bupropion Hydrochloride; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 23
States / cities: Berkeley, California • Beverly Hills, California • La Mesa, California + 20 more

Conditions: Nonsmall Cell Lung Cancer
Interventions: Exercise; Behavioral
Lead sponsor: University of Vermont; Other
Eligibility: 50 Years to 75 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Cognitive Disorders, HIV Infections
Interventions: Selegiline hydrochloride; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2005
U.S. locations: 12
States / cities: Los Angeles, California • San Diego, California • Stanford, California + 6 more

Conditions: Hypoactive Sexual Desire Disorder, Sexual Dysfunctions, Psychological
Interventions: Ginkgo Biloba, Sex Therapy (genital focus); Drug · Behavioral
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 18 Years to 65 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2004
U.S. locations: 1
States / cities: Austin, Texas

Search by objective public record fields.

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Study to Investigate the Efficacy and Safety of Vardenafil Flexible Dose Versus Placebo in Males With Erectile Dysfunction

A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of LasoperinTM on Cognitive Function in Healthy Adults

Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas

OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.

ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults

Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTD

The Effect of Inflammation in Heart Failure

Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)

Health Interventions in Men Undergoing Radical Prostatectomy

Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease

Uric Acid and the Endothelium in CKD

Age-Related Changes in Body Composition

Clinical Study Using Eye Lipid Mobilizer (ELM) With Heat and Vibration To Treat Evaporative Dry Eye Disease

Sexual Function Trial of Overactive Bladder: Medication Versus PTNS

Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease

Light and Sleep Fragmentation

Sensitivity to Change of the Lower Extremity Functional Scale in Patients With Stroke

Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)

Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis

Effects of Antidepressants on Sexual Functioning

Skeletal Muscle Atrophy and Dysfunction in Human Cancer

A Study of Decreased Mental Function Associated With HIV

Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction